- FRTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Fresh Tracks Therapeutics (FRTX) S-3Shelf registration
Filed: 25 May 18, 1:01pm
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-3) and related Prospectus of Vical Incorporated for the registration of up to $40,000,000 in aggregate principal of its common stock, preferred stock, debt securities and warrants and to the incorporation by reference therein of our reports dated March 15, 2018, with respect to the financial statements of Vical Incorporated included in its Annual Report (Form 10-K) for the year ended December 31, 2017, filed with the Securities and Exchange Commission.
/s/Ernst & Young LLP
San Diego, California
May 25, 2018
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.